What is the recommended dosage and usage of Tranxene (clorazepate) for anxiety disorders and alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage and Usage of Tranxene (Clorazepate) for Anxiety Disorders and Alcohol Withdrawal

For anxiety disorders, Tranxene (clorazepate) should be administered at 15-60 mg daily in divided doses, with a usual daily dose of 30 mg; for alcohol withdrawal, follow a tapering schedule starting with 30-60 mg on day 1, gradually reducing to 7.5-15 mg before discontinuation. 1

Dosage for Anxiety Disorders

Standard Adult Dosing

  • Initial dose: 30 mg daily in divided doses
  • Dose range: 15-60 mg daily, adjusted based on patient response
  • Alternative single bedtime dosing: 15 mg initially, then adjusted based on response

Special Populations

  • Elderly or debilitated patients:
    • Start with 7.5-15 mg daily
    • Lower doses generally indicated for elderly patients

Administration Considerations

  • May be given in divided doses throughout the day or as a single bedtime dose
  • Drowsiness may occur at treatment initiation or with dose increases
  • Single nighttime dosing (15 mg) has been shown to be effective for short-term anxiety treatment 2

Dosage for Alcohol Withdrawal

Recommended Tapering Schedule

Time Period Dosage
Day 1 30 mg initially, followed by 30-60 mg in divided doses
Day 2 45-90 mg in divided doses
Day 3 22.5-45 mg in divided doses
Day 4 15-30 mg in divided doses
Thereafter Gradually reduce to 7.5-15 mg daily

Important Considerations

  • Maximum recommended total daily dose: 90 mg
  • Avoid excessive reductions in daily dose on successive days
  • Discontinue as soon as the patient's condition stabilizes 1
  • Benzodiazepines are effective for controlling alcohol withdrawal by addressing noradrenergic and hypothalamic-pituitary-adrenocortical overactivity 3
  • Medication should be dispensed in small quantities or each dose supervised to reduce misuse risk 4

Adjunctive Treatment Considerations

Psychosocial Support

  • Psychosocial support should be routinely offered to alcohol-dependent patients 4
  • Where available, consider more structured psychological interventions such as motivational techniques 4
  • Encourage engagement with mutual help groups like Alcoholics Anonymous 4

Safety Precautions

  • Long-term use can lead to tolerance, addiction, and cognitive impairment
  • Paradoxical agitation occurs in approximately 10% of patients treated with benzodiazepines
  • Despite clorazepate's long half-life, withdrawal reactions can still occur with abrupt discontinuation 5
  • Patients at risk of severe withdrawal or with concurrent serious physical/psychiatric disorders should preferably be managed in an inpatient setting 4

Monitoring and Follow-up

  • Regular monitoring for side effects including sedation, cognitive impairment, and falls
  • For alcohol withdrawal patients, monitor vital signs and level of sedation
  • Withdrawal from benzodiazepines should be undertaken in a planned manner, using a gradually tapering dose over 8-12 weeks 4
  • Consider additional psychosocial support during benzodiazepine withdrawal

Clorazepate at 7.5 mg daily has been shown to provide useful anxiolytic effects without excessive sedation 6, which may be particularly important for patients who need to maintain daily functioning while managing anxiety symptoms.

References

Research

Anxiety and alcoholism.

The Journal of clinical psychiatry, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Withdrawal responses to abrupt discontinuation of desmethyldiazepam.

The American journal of psychiatry, 1984

Research

Physiological and psychological effects of clorazepate in man.

British journal of clinical pharmacology, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.